Noromectin Drench
Norodine 24 Solution for Injection is indicated in the treatment of acute, subacute and chronic conditions of bacterial origin in horses, cattle, pigs, dogs and cats. The therapeutic spectrum includes both Gram-negative and Gram-positive bacteria and it is also indicated in species where there may be an existing antibiotic drug resistance.
Target Species: Beef cattle, dairy cattle, horses, pigs, dogs and cats
-
Active Ingredient
Trimethoprim 4.00% w/v Sulfadiazine 20.00% w/v
-
Pharmaceutical Form
Solution For Injection A sterile clear yellow aqueous solution
-
Indications
Norodine 24 Injectable Solution is indicated in the treatment of systemic infections caused by or associated with organisms sensitive to the Trimethoprim: Sulfadiazine combination. The spectrum of activity includes both Gram-positive and Gram-negative organisms including: Actinobacilli, Actinomycae, Bordetella spp, Brucella Corynebacteria, Escherichia coli, Haemophilus spp, Klebsiella spp, Pasteurella spp, Pneumococci, Proteus, Salmonella spp, Staphylococci, Streptococci, Vibrio.
-
Dosage
Cattle and Pigs: The recommended dose rate is 15 mg of active ingredients per kilogram bodyweight (1 ml per 16 kg bodyweight) by intramuscular or slow intravenous injection. Norodine 24 Injectable Solution may be administered by intravenous injection when rapid blood levels of trimethoprim and Sulfadiazine are required. Horses: The recommended dose rate is 15 mg of active ingredients per kilogram bodyweight (1 ml per 16 kg bodyweight), by slow intravenous injection. Dogs and Cats: The recommended dose rate is 30 mg of active ingredients per kilogram bodyweight (1 ml per 8 kg bodyweight), by subcutaneous injection only. The recommended site in dogs is the loose skin at the top of the neck. A single injection may be sufficient in uncomplicated conditions, but in severe infections it may be repeated daily until 2 days after symptoms resolve, up to a maximum of 5 days. An appropriately graduated syringe must be used to allow accurate administration of the required dose volume. This is particularly important when injecting small volumes.
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.
Prefer to speak directly to a member of our team?
Norbrook MENA
All enquiries for the MENA team are manged by the Norbrook Head Office in Northern Ireland
We are open Mon - Fri 9:00am - 5:00pm